PharmaTech

MARCH 13, 2024

Webinar Date/Time: Wed, Apr 24, 2024 11:00 AM EDT

Drug Development 52

Drug Development 52

European Pharmaceutical Review

FEBRUARY 22, 2024

A report by Towards Healthcare has forecasted that the advanced drug delivery market will value $375.86 The year 2023 was “significant” for the progress of advanced drug delivery systems, the author reflected. This method delivers the anti-nausea drug thioperamide to treat post-surgery sickness. billion by 2033.

83

83

Express Pharma

MARCH 20, 2024

Its pharma division is a world-class producer of excipients for oral dosage solutions, with revenues of approximately $1B, 10 research and development and/or production sites globally, and around 1,100 employees. IFF is headquartered in New York (USA). Roquette and IFF target to close the transaction in the first half of 2025.

Dosage 101

Dosage 101

European Pharmaceutical Review

MARCH 4, 2024

1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs. Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5

Vaccines 88

Vaccines Immunity Immunization Compounding 88

European Pharmaceutical Review

FEBRUARY 14, 2024

This was due to these systems offering a “direct and rapid route for drug delivery.” This was due to these systems offering a “direct and rapid route for drug delivery.” As suspensions enhance the solubility and bioavailability of certain drugs, this has made them preferable for cancer therapeutics, the research noted. 

71

71

Outsourcing Pharma

JANUARY 18, 2024

With innovative and flexible lab and manufacturing solutions being a critical success factor in drug development and delivery, SmartLabs, was delighted to announce the raise of $48 million series C financing.

Drug Development 83

Drug Development 83

European Pharmaceutical Review

JANUARY 15, 2024

The natural polymer tara gum polysaccharide ( Caesalpinia spinosa ) has application potential in pharmaceutical drug delivery , according to researchers in Korea. Sustainability crucial for pharma’s supply chain future The post Could plastic alternative support environmentally-sustainable drug delivery?

85

85

World Pharma News

FEBRUARY 22, 2024

University of North Carolina at Chapel Hill researchers have developed a new drug delivery platform that harnesses helical amyloid fibers designed to untwist and release drugs in response to body temperatures. A new research paper published on Jan.

Communication 86

Communication 86

European Pharmaceutical Review

MAY 7, 2024

A novel intravesical targeted drug delivery system for patients with bladder cancer has demonstrated positive data in updated results from a Phase I trial. Johnson & Johnson’s Phase I study is assessing the safety and efficacy of TAR-210 as a delivery method for sustained, local release of erdafitinib into the bladder.

Hospitals 76

Hospitals 76

Pharmaceutical Technology

MARCH 27, 2024

Labor And Delivery disease is an indication for drug development with over 10 pipeline drugs currently active according to GlobalData.

Drug Development 52

Drug Development 52

Outsourcing Pharma

NOVEMBER 27, 2023

1nhaler, a Scotland-based drug delivery device developer, has raised Â2 million to develop its single-use dry powder inhaler (DPI).

74

74

Express Pharma

MAY 16, 2024

IntegriMedical has developed a US patented Needle-Free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs.

66

66

Express Pharma

APRIL 26, 2024

Leveraging our internal Parexel expertise and our strategic partnership with Palantir, we have novel solutions already in use or in various stages of development that demonstrate our commitment to be a fully digital CRO.” The post Parexel partners with Palantir to accelerate clinical data delivery appeared first on Express Pharma.

Drug Development 99

Drug Development 99

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. The investment aims to improve vaccines and shorten the time it takes to produce medicines.

Vaccines 86

Vaccines Packaging 86

pharmaphorum

SEPTEMBER 23, 2020

Sixfold Bioscience in partnership with Medicines Discovery Catapult, has been given the green light, through the award of an Innovate UK Smart Grant to test a pioneering system designed to deliver drugs directly to cancerous cells, without impacting the healthy cells around it.

Drug Development 141

Drug Development 141

pharmaphorum

MARCH 13, 2024

Join SAE at the Pre-Filled Syringes West Coast Conference to explore the latest developments in drug delivery technology. Connect with industry experts and stay ahead of the curve.

52

52

European Pharmaceutical Review

SEPTEMBER 4, 2023

Maciej Adamczyk and Monika Pyzio-Michalik, DBS Law Firm EVENT PREVIEW Modern methods in microbiology and analytics PharmaLab Congress DRUG DELIVERY Dry powder delivery to the lungs Jnanadeva Bhat, ACG EVENT PREVIEW CPHI Barcelona 2023: what to expect Featuring company profiles from BioSpectra, Lonza and Ajinomoto VACCINE DEVELOPMENT The imperative (..)

Packaging 78

Packaging Vaccines Immunity Immunization 78

European Pharmaceutical Review

APRIL 14, 2023

The current progress, challenges and opportunities for achieving stable formulations of nucleic acid (NA) therapeutics with novel drug delivery systems (DDSs) has been discussed in a paper published in Pharmaceutics. This specialised handling results in the drugs being more expensive. acknowledged. Ingle et al.

Dosage 98

Dosage Vaccines 98

pharmaphorum

MARCH 20, 2024

Join industry experts at the Next Gen Peptide Formulation & Delivery Summit to explore the latest advancements in peptide drug development and formulation techniques. Learn from leaders in the field and network with peers in this cutting-edge event.

Drug Development 52

Drug Development 52

European Pharmaceutical Review

DECEMBER 22, 2022

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Immunity 105

Immunity Immunization Vaccines Hospitals 105

Pharmaceutical Business Review

JANUARY 18, 2024

The move is set to enhance Kindeva’s drug-delivery capabilities by adding a new platform to its portfolio. Kindeva CEO Milton Boyer said: “Nasal drug delivery is becoming a preferred dosage format for a growing number of indications, as it allows users to non-invasively administer medications in an acute or emergency setting.

Dosage 59

Dosage 59

STAT

MARCH 9, 2023

Already, there was a burst of activity here on the Pharmalot campus, where the official mascot stared down a delivery person and then nearly cornered a furry creature running across the grounds. The failure was expected by some in the Alzheimer’s field after the drug failed in previous studies.

189

189

Pharmaceutical Business Review

DECEMBER 27, 2023

Designed based on the Ligand and Enhancer Assisted Delivery (LEAD) platform of SanegeneBio, SGB-3908 is currently in the investigational new drug application (IND)-enabling stage of development. Both Innovent and SanegeneBio will jointly advance the SGB-3908 development until a specific stage.

Drug Development 59

Drug Development 59

Pharmafile

FEBRUARY 13, 2024

DelSiTech and Tolmar International have announced that they have entered into a global license and development agreement, following a previous investment from Tolmar in January 2024.

59

59

European Pharmaceutical Review

AUGUST 4, 2023

The joint government-industry investment will aid capability and capacity for the drug delivery device contract development and manufacturing organisation (CDMO) Kindeva Drug Delivery to manufacture next generation green pressurised metered-dose inhalers (pMDIs).

Packaging 81

Packaging Pharmaceutical Companies Pharmaceutical Companies 81

European Pharmaceutical Review

DECEMBER 1, 2023

During CPHI Barcelona, EPR Editor Caroline Peachey asked Anil Kane, Global Head of Technical & Scientific Affairs, Pharma Services, at Thermo Fisher Scientific about the dynamic landscape of pharmaceutical drug development. What are the trends affecting drug development today?

Drug Development 83

Drug Development Dosage Diabetes Process Improvement 83

PharmaTech

SEPTEMBER 24, 2023

This makes them suitable for inhalation drug delivery. However, successful implementation of jet milling requires a robust Quality by Design (QbD) approach that ensures the critical quality attributes of the micronized particles are maintained throughout the process development.

Drug Development 52

Drug Development 52

European Pharmaceutical Review

FEBRUARY 21, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL (..)

Drug Development 100

Drug Development 100

European Pharmaceutical Review

AUGUST 15, 2023

The global buccal drug delivery market is projected to grow from $3.38 Buccal drug delivery involves administration of a drug through buccal mucosa membrane lining of the oral cavity, with the drug usually placed between the upper gums and cheeks. The post Buccal drug delivery market to reach $7.1b

Dosage 52

Dosage Compounding 52

European Pharmaceutical Review

OCTOBER 25, 2023

Winners of the 2023 CPHI Pharma Award – highlights For spearheading Procos’ growth, the company’s CEO Enrico Zodio, won CEO of the Year award for enabling the contract development and manufacturing organisation (CDMO) to achieve a current turnover in excess of €200 million.

Packaging 90

Packaging 90

Express Pharma

APRIL 4, 2024

True enough, the use of liposomes and LNPs as carriers for highly specialised drug and biologic payloads, notably mRNA therapies, has experienced remarkable growth—notably, the initial SARS-CoV-2 vaccines authorised for use employed LNPs as delivery mechanisms for mRNA payloads. So, in that sense, both are effective in drug delivery.

Vaccines 77

Vaccines Compounding Immunity Immunization 77

Express Pharma

JULY 29, 2023

Panelists in this video: + Dr Sunil Tiwari, Sr VP R&D, Hetero Drugs + Dr Vaibhav Sihorkar, VP & Head- Developability & Formulations, Sai Life Sciences + Dr Sajeev Chandran, VP-R&D, Lupin + Dr Amarender Reddy Donthidi, VP & Head – R&D Injectables and Ophthalmics, Amneal Pharmaceuticals + Dr Abir Banerjee, VP-R&D (..)

Dosage 52

Dosage Vaccines 52

European Pharmaceutical Review

APRIL 14, 2023

Oligonucleotide therapeutics represent a relatively novel class of drug, with the potential to modulate drug targets that were previously considered intractable, and with the benefit of fast clinical development times. Small interfering RNA (siRNA) were one of the most preferred drug delivery methods. The answers?

Drug Development 86

Drug Development Vaccines 86

Pharmaceutical Technology

SEPTEMBER 7, 2022

Indian company Bharat Biotech International has secured approval from Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for its intranasal Covid-19 vaccine, iNCOVACC (BBV154), for usage in people aged 18 years and older. It is formulated to permit intranasal delivery via nasal drops.

Vaccines 105

Vaccines 105

PharmaTech

SEPTEMBER 29, 2023

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

52

52

PharmaTech

MAY 19, 2023

Shabbir Mostafa, head of Business Development — Advanced Delivery Systems, Recipharm, sat down with Grant Playter, associate editor, during DCAT week to discuss the current state of inhalations forms and drug delivery.

52

52

Pharmaceutical Business Review

APRIL 19, 2024

This partnership follows the US Food and Drug Administration’s approval of ADSTILADRIN in December 2022 for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.

64

64